An Unbiased View of Landscape
Although the risk of attaining HIV is considerably diminished between prolonged acting cabotegravir PrEP people, thus far, ten circumstances of integrase inhibitor drug resistance are already reported among the people who received long acting cabotegravir PrEP, and all ten scenarios experienced mutations that confer cross-resistance to dolutegravir